TrialEuropean journal of clinical pharmacology2006

Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study.

K Spargias et al.PubMed ↗Publisher ↗

No numbers read from the abstract.